Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

137.74
Delayed Data
As of Jul 21
 +1.43 / +1.05%
Today’s Change
96.93
Today|||52-Week Range
138.17
+19.00%
Year-to-Date

Today’s Trading

Previous close136.31
Today’s open136.23
Day’s range135.72 - 138.17
Volume3,651,611
Average volume (3 months)3,741,042
Market cap$107.6B
Dividend yield--
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.63%
Earnings growth (next 5 years)+20.06%
Revenue growth (last year)+22.70%
P/E ratio51.8
Price/Sales8.51
Price/Book16.25

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.11-0.26%
ABBVAbbVie+0.62+0.84%
LLYEli Lilly and Co-0.09-0.11%
SNYSanofi-0.35-0.73%
Data as of 07/21/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts